Controversy Surrounding Kelly Osbourne’s Support for Ozempic Weight Loss Trend Sparks Backlash

Kelly Osbourne‘s recent comments endorsing the use of the Type 2 diabetes medication, Ozempic, for weight loss have stirred controversy and sparked backlash.

The TV personality, known for her appearances on E! News and Hollywood events, shared her support for the once-weekly semaglutide injection during an interview.

Speaking at ‘Dolly Parton‘s Pet Gala,’ Osbourne praised Ozempic as ‘amazing’ and criticized those who question its use for weight loss purposes.

Osbourne claimed that the backlash against Ozempic stems from individuals who either envy its effectiveness or cannot afford it.

She emphasized that the medication’s high cost inhibits access for people with Type 2 diabetes who require it for managing their condition.

Despite the endorsement from Kelly Osbourne, her mother Sharon Osbourne, a prominent TV personality, holds a contrasting view on using Ozempic for weight loss.

In a separate interview with NBC News, Sharon Osbourne cautioned about the risks of becoming addicted to weight loss from the medication.

Concerns have been raised regarding the lack of availability of Ozempic for diabetic patients due to the overwhelming demand driven by its weight loss effects among non-diabetic users.

The widespread use of Ozempic for weight loss in Hollywood and beyond has brought attention to the challenges faced by individuals with Type 2 diabetes in accessing necessary medications.